|Anterior chamber bleeding after laser peripheral iridotomy.|
|PMID: 23538479 Owner: NLM Status: MEDLINE|
|IMPORTANCE: To our knowledge, this is the first study to describe the correlation of anterior chamber bleeding after laser peripheral iridotomy (LPI) and antiplatelet therapy.
OBJECTIVE: To determine the incidence and amount of anterior chamber bleeding after laser peripheral iridotomy in patients whose condition is suggestive of primary angle-closure glaucoma (PACS) who continued their antiplatelet or anticoagulant treatment before undergoing LPI compared with when they discontinued treatment.
DESIGN AND SETTING: A prospective controlled trial.
PATIENTS: Patients with suspected bilateral primary angle-closure and no other ocular disease who take antiplatelet or anticoagulant medications regularly (from January 2010-October 2011) were enrolled.
MAIN OUTCOME AND MEASURE: The incidence of anterior chamber bleeding with and without antiplatelet and anticoagulant therapy.
RESULTS: A total of 104 patients (208 eyes) participated in the study. Thirty-six eyes (34.6%) in the treated and untreated arms bled. The amount of bleeding did not differ significantly when the patient was on or off antiplatelet or anticoagulant treatment, nor did the immediate postprocedure mean intraocular pressure (P = .13). The type of antiplatelet or anticoagulant, total laser energy, age, sex, or color of irides were not risk factors for increased bleeding (P = .156 for all parameters).
CONCLUSIONS: No indication was noted for discontinuing these medications before a high-powered pulsed laser peripheral iridotomy.
|Shani Golan; Hani Levkovitch-Verbin; Gabi Shemesh; Shimon Kurtz|
Related Documents :
|23518619 - Clinical efficacy of botanical extracts from eupatorium adenophorum against the sarcopt...
23001579 - Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases...
23660549 - Limb salvage treatment for gollop-wolfgang complex (femoral bifurcation, complete tibia...
24720919 - Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospe...
24285349 - Short and medium-term therapeutic effects of pneumatic dilatation for achalasia: a 15-y...
24756139 - Early changes of parotid density and volume predict modifications at the end of therapy...
16451159 - Transarterial block as an addition to a conventional catheter technique improves the ax...
12440619 - Ruptured sinus of valsalva aneurysm: a beijing experience.
10735779 - Does intraoperative hetastarch administration increase blood loss and transfusion requi...
|Type: Controlled Clinical Trial; Journal Article|
|Title: JAMA ophthalmology Volume: 131 ISSN: 2168-6173 ISO Abbreviation: JAMA Ophthalmol Publication Date: 2013 May|
|Created Date: 2013-06-07 Completed Date: 2013-07-26 Revised Date: 2013-11-06|
Medline Journal Info:
|Nlm Unique ID: 101589539 Medline TA: JAMA Ophthalmol Country: United States|
|Languages: eng Pagination: 626-9 Citation Subset: AIM; IM|
|Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Aged, 80 and over
Anterior Chamber / pathology
Anticoagulants / therapeutic use*
Aspirin / therapeutic use
Glaucoma, Angle-Closure / prevention & control*
Hyphema / etiology*
Iris / surgery
Lasers, Solid-State / therapeutic use
Platelet Aggregation Inhibitors / therapeutic use*
Ticlopidine / analogs & derivatives, therapeutic use
Warfarin / therapeutic use
|0/Anticoagulants; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 55142-85-3/Ticlopidine; 81-81-2/Warfarin; A74586SNO7/clopidogrel|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Line Transect and Triangulation Surveys Provide Reliable Estimates of the Density of Kloss' Gibbons ...
Next Document: Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.